SLC31A1 and pancreatic ductal adenocarcinoma: In pancreatic duct adenocarcinoma (PDAC), characterized by abnormal copper accumulation, targeting the copper transporter 1 (SLC31A1), or the treatment with a copper chelator, induce a dormancy-like response sustained by increased autophagy to resist cell death both in in vitro and in vivo models [60].